Sunday, October 21, 2012

Strides Arcolab gets USFDA approval; stock gains

Strides Arcolab  has received US FDA approval for Idarubicin Injection, reports CNBC-TV18.

At 09:27 hrs Strides Arcolab was quoting at Rs 906, up Rs 9.40, or 1.05%. It has touched an intraday high of Rs 907.00 and an intraday low of Rs 894.
 
It was trading with volumes of 5,876 shares. In the previous trading session, the share closed up 0.78% or Rs 6.90 at Rs 896.60. 
 
The share touched its 52-week high Rs 958.10 and 52-week low Rs 374.00 on 10 September, 2012 and 18 October, 2011, respectively. 
 
Currently, it is trading 5.44% below its 52-week high and 142.25% above its 52-week low. 
 
Market capitalisation stands at Rs 5,321.73 crore.

No comments:

Post a Comment

Please feel free to contact or comment the article

Search This Blog